NCT04221178: Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission

• NCT04221178: Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission
  

NCT04221178: Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission

This study will test whether stopping maintenance therapy in people with multiple myeloma in MRD-negative remission has the same effect on disease control as continuing this therapy. The study will look at whether people currently on maintenance therapy can safely stop this treatment and continue with active surveillance instead while keeping their MRD-negative remission status for at least 1 year.

Sponsor

Memorial Sloan Kettering Cancer Center

---

ClinicalTrials.gov Identifier: NCT04221178

Official Title: A Single-Arm, Prospective Study of Maintenance Therapy Cessation for Patients With Multiple Myeloma in Sustained MRD-Negative Remissions

First Posted : January 9, 2020

Click here for details on ClinicalTrials.gov

---

Other: Cessation of continuous maintenance therapy

---

- New York: Memorial Sloan-Kettering Cancer Center New York

https://www.mskcc.org/cancer-care/clinical-trials/19-422

---

Location

United States, New Jersey

United States, New York